0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessEarly relapses and substantial MRI activity in the first year of treatment are associated with worse short-term outcomes in patients treated with some of the oral DMTs.
Serena Ruggieri, Luca Prosperini, Sarmad Al‐Araji, Pietro Annovazzi, Alvino Bisecco, Olga Ciccarelli, Nicola De Stefano, Massimo Filippi, Vinzenz Fleischer, Nikos Evangelou, Christian Enzinger, Antonio Gallo, Afagh Garjani, Sergiu Groppa, Shalom Haggiag, Michael Khalil, Matteo Lucchini, Massimiliano Mirabella, Xavier Montalbán, Carlo Pozzilli, Paolo Preziosa, Jordi Río, Maria A. Rocca, Àlex Rovira, Maria Laura Stromillo, Mauro Zaffaroni, Carla Tortorella, Claudio Gasperini (2023). Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study. , 95(2), DOI: https://doi.org/10.1136/jnnp-2023-331920.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2023
Authors
28
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1136/jnnp-2023-331920
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
